Allergan (AGN), Mylan (MYL) Sees Short Interest Rise, Gilead (GILD) Fall in Pharma Sector - Guggenheim

Guggenheim analyst Louise Chen provided a quick analysis of the latest short interest data (09/15/16) in the pharma sector.

Chen notes the largest increase in short interest is Aralez (NASDAQ: ARLZ) at +26.3%, followed closely by Allergan (NYSE: AGN) at +24.7%.

The company with the largest decrease in short interest is Gilead (NASDAQ: GILD) at -10.4%.

Other Notables:

Mylan, Inc. (NYSE: MYL) short interest up 17.7% to 25,313,358 shares.

Valeant Pharmaceuticals Inc. (NYSE: VRX) short interest up 1.2% to 26,396,945.

Bristol Myers Squibb (NYSE: BMY) short interest up 13.1% to 13,960,166 shares

Endo Pharmaceuticals (NASDAQ: ENDP) short interest up 16.7% to 16,003,377 shares.

Celgene (NASDAQ: CELG) short interest up 18.7% to 6,953,530 shares.

You May Also Be Interested In

• UnitedHealth Group (UNH) CEO to testify at May 1 House Panel hearing
• Midday top small-cap gainers
• Super Micro Computer (SMCI) now down nearly 20%